Allergy Therapeutics plc announced that Nick Wykeman Board Director has tendered his resignation, with effect from November 30, 2022, in order to pursue non-executive roles. Nick Wykeman, who has been a Director of Allergy Therapeutics for six years, remains in his role for six months and a search for his successor will now commence.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.65 GBX | +7.35% | +8.96% | +46.00% |
1st Jan change | Capi. | |
---|---|---|
+46.00% | 206M | |
+12.30% | 116B | |
+12.15% | 106B | |
-8.14% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.33% | 16.33B | |
+5.80% | 14.14B | |
+28.03% | 12.02B |
- Stock Market
- Equities
- AGY Stock
- News Allergy Therapeutics plc
- Allergy Therapeutics plc Announces Resignation of Nick Wykeman to Its Board Director, Effective from November 30, 2022